AbbVie 2013 Annual Report Download - page 112

Download and view the complete annual report

Please find page 112 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 176

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176

EXHIBIT INDEX
ABBVIE INC.
ANNUAL REPORT
FORM 10-K
2013
Exhibits 32.1 and 32.2 are furnished herewith and should not be deemed to be ‘‘filed under the
Securities Exchange Act of 1934.’’
Exhibit
Number Exhibit Description
2.1 *Separation and Distribution Agreement dated as of November 28, 2012 by and between
Abbott Laboratories and AbbVie Inc. (incorporated by reference to Exhibit 2.1 of
Amendment No. 6 to the Company’s Registration Statement on Form 10 filed on
November 30, 2012).
3.1 *Amended and Restated Certificate of Incorporation of AbbVie Inc. (incorporated by
reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed on January 2,
2013).
3.2 *Amended and Restated By-Laws of AbbVie Inc. (incorporated by reference to Exhibit 3.2 of
the Company’s Current Report on Form 8-K filed on January 2, 2013).
4.1 *Indenture dated as of November 8, 2012 between AbbVie Inc. and U.S. Bank National
Association (incorporated by reference to Exhibit 4.1 of Amendment No. 5 to the Company’s
Registration Statement on Form 10 filed on November 16, 2012).
4.2 *Supplemental Indenture No. 1 dated as of November 8, 2012 among AbbVie Inc. and U.S.
Bank National Association (incorporated by reference to Exhibit 4.2 of Amendment No. 5 to
the Company’s Registration Statement on Form 10 filed on November 16, 2012).
10.1 *U.S. Transition Services Agreement dated as of December 31, 2012 by and between Abbott
Laboratories and AbbVie Inc. (incorporated by reference to Exhibit 10.1 of the Company’s
Current Report on Form 8-K filed on January 2, 2013).
10.2 *Ex-U.S. Transition Services Agreement dated as of December 31, 2012 by and between
Abbott Laboratories and AbbVie Inc. (incorporated by reference to Exhibit 10.2 of the
Company’s Current Report on Form 8-K filed on January 2, 2013).
10.3 *Tax Sharing Agreement entered into as of December 31, 2012 by and between Abbott
Laboratories and AbbVie Inc. (incorporated by reference to Exhibit 10.3 of the Company’s
Current Report on Form 8-K filed on January 2, 2013).
10.4 *Special Products Master Agreement dated as of December 31, 2012 by and between Abbott
Laboratories and AbbVie Inc. (incorporated by reference to Exhibit 10.4 of the Company’s
Current Report on Form 8-K filed on January 2, 2013).
10.5 *Employee Matters Agreement dated as of December 31, 2012 by and between Abbott
Laboratories and AbbVie Inc. (incorporated by reference to Exhibit 10.5 of the Company’s
Current Report on Form 8-K filed on January 2, 2013).
10.6 *International Commercial Operations Agreement dated as of December 31, 2012 by and
between Abbott Laboratories and AbbVie Inc. (incorporated by reference to Exhibit 10.6 of
the Company’s Current Report on Form 8-K filed on January 2, 2013).
10.7 First Amendment to International Commercial Operations Agreement effective as of
December 31, 2012 by and between Abbott Laboratories and AbbVie Inc.
108